{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:03:45Z","timestamp":1789470225806,"version":"build-2803163510"},"reference-count":72,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2026.2185","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:47:58Z","timestamp":1786362478000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["<i>In vitro<\/i>\n                    activity and clinical use of cefiderocol against\n                    <i>Achromobacter xylosoxidans<\/i>\n                    (Review)"],"prefix":"10.3892","volume":"25","author":[{"given":"Federico","family":"Giovagnorio","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Azienda Sanitaria Friuli Occidentale Santa Maria degli Angeli Hospital of Pordenone, I\u201133170 Pordenone, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Colpani","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medicine, San Francesco Hospital, I\u201108100 Nuoro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Vito","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, I\u201107100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marino","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, Azienta Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi Hospital, University of Catania, I\u201195122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"Madeddu","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, I\u201107100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nunnari","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, Azienta Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi Hospital, University of Catania, I\u201195122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Bella","sequence":"additional","affiliation":[{"name":"Clinical Department of Medical, Surgical and Health Sciences, Trieste University, I\u201134129 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Geremia","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale dell'Angelo, I\u201130174 Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"key20260915130955_b1-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QCO.0000000000000969","article-title":"The microbiology and pathogenesis of nonfermenting gram-negative infections","volume":"36","author":"Di Pilato","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"306","key":"key20260915130955_b2-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030306","article-title":"Rare or unusual non-fermenting gram-negative bacteria: Therapeutic approach and antibiotic treatment options","volume":"14","author":"Geremia","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"key20260915130955_b3-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"e01025","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options","volume":"64","author":"Isler","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"key20260915130955_b4-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1513\/AnnalsATS.201406-288FR","article-title":"Achromobacter respiratory infections","volume":"12","author":"Swenson","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"2437","key":"key20260915130955_b5-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072437","article-title":"The association of Achromobacter xylosoxidans airway infection with disease severity in cystic fibrosis","volume":"14","author":"Bar-On","year":"2025","journal-title":"J Clin Med"},{"key":"key20260915130955_b6-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.rmcr.2017.01.005","article-title":"Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports","volume":"20","author":"Firmida","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"key20260915130955_b7-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/jcm.19.2.140-143.1984","article-title":"Nosocomial colonization and infection by Achromobacter xylosoxidans","volume":"19","author":"Reverdy","year":"1984","journal-title":"J Clin Microbiol"},{"key":"key20260915130955_b8-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/00365548.2013.857043","article-title":"Skin and soft tissue infection caused by Achromobacter xylosoxidans: Report of 14 cases","volume":"46","author":"Tena","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"key20260915130955_b9-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bjid.2013.01.008","article-title":"Bacteremia due to Achromobacter xylosoxidans in neonates: Clinical features and outcome","volume":"17","author":"Turel","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"key20260915130955_b10-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0034-1396929","article-title":"Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: Antimicrobial resistance and therapeutic strategies","volume":"36","author":"Abbott","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"key20260915130955_b11-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1179\/joc.2009.21.3.253","article-title":"Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy","volume":"21","author":"Nicolosi","year":"2009","journal-title":"J Chemother"},{"issue":"e0026425","key":"key20260915130955_b12-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00264-25","article-title":"Defining antimicrobial susceptibility testing methods and breakpoints among Achromobacter species","volume":"63","author":"Harris","year":"2025","journal-title":"J Clin Microbiol"},{"issue":"9265","key":"key20260915130955_b13-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169265","article-title":"Achromobacter Spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance","volume":"23","author":"Sandri","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260915130955_b14-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"S519","DOI":"10.1093\/cid\/ciz823","article-title":"Cefiderocol: A novel siderophore cephalosporin defeating carbapenem-resistant pathogens","volume":"69 (Suppl 7)","author":"Bonomo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key20260915130955_b15-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.2147\/IDR.S475462","article-title":"Effectiveness and safety of cefiderocol in clinical practice for treatment of patients with gram-negative bacterial infections: US interim results of the PROVE study","volume":"17","author":"Clancy","year":"2024","journal-title":"Infect Drug Resist"},{"key":"key20260915130955_b16-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40121-025-01147-w","article-title":"From clinical trials to real-world experiences: Evidence about cefiderocol use and potential role in empirical therapy","volume":"14","author":"Russo","year":"2025","journal-title":"Infect Dis Ther"},{"issue":"e0034623","key":"key20260915130955_b17-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00346-23","article-title":"In vitro and in vivo activity of cefiderocol against Achromobacter Spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates","volume":"67","author":"Takemura","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"key20260915130955_b18-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10096-025-05109-5","article-title":"Cefiderocol treatment for patients infected by Stenotrophomonas maltophilia, Burkholderia cepacia complex and Achromobacter Spp.: Subgroup analysis from the PERSEUS study","volume":"44","author":"Torre-Cisneros","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"54","key":"key20260915130955_b19-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-024-00709-z","article-title":"Cefiderocol susceptibility of Achromobacter Spp.: Study of an accurately identified collection of 230 strains","volume":"23","author":"Jean-Pierre","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"127140","key":"key20260915130955_b20-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127140","article-title":"Achromobacter Spp. prevalence and adaptation in cystic fibrosis lung infection","volume":"263","author":"Veschetti","year":"2022","journal-title":"Microbiol Res"},{"key":"key20260915130955_b21-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"261","DOI":"10.53854\/liim-3303-2","article-title":"Managing multidrug-resistant Pandoraea Spp.: Current evidence and knowledge gaps","volume":"33","author":"Geremia","year":"2025","journal-title":"Infez Med"},{"key":"key20260915130955_b22-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1128\/JCM.02556-16","article-title":"Prevalence and outcomes of Achromobacter species infections in adults with cystic fibrosis: A North American cohort study","volume":"55","author":"Edwards","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key20260915130955_b23-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.26355\/eurrev_202209_29664","article-title":"Nosocomial outbreak of Achromobacter Spp. bacteremia due to germicide contamination: A systematic review","volume":"26","author":"Yoon","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"e114356","key":"key20260915130955_b24-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114356","article-title":"Genotypic and phenotypic applications for the differentiation and species-level identification of Achromobacter for clinical diagnoses","volume":"9","author":"Gomila","year":"2014","journal-title":"PLoS One"},{"issue":"105889","key":"key20260915130955_b25-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2020.105889","article-title":"Expansion and improvement of MALDI-TOF MS databases for accurate identification of Achromobacter species","volume":"172","author":"Papalia","year":"2020","journal-title":"J Microbiol Methods"},{"key":"key20260915130955_b26-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcf.2012.10.002","article-title":"Identification and distribution of Achromobacter species in cystic fibrosis","volume":"12","author":"Spilker","year":"2013","journal-title":"J Cyst Fibros"},{"key":"key20260915130955_b27-BR-25-4-02185"},{"key":"key20260915130955_b28-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/JCM.39.11.3942-3945.2001","article-title":"Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis","volume":"39","author":"Saiman","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key20260915130955_b29-BR-25-4-02185"},{"key":"key20260915130955_b30-BR-25-4-02185"},{"issue":"1673","key":"key20260915130955_b31-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121673","article-title":"Fluoroquinolones and biofilm: A narrative review","volume":"17","author":"Geremia","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20260915130955_b32-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1128\/AAC.04260-14","article-title":"Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans","volume":"59","author":"Hu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"e0008025","key":"key20260915130955_b33-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00080-25","article-title":"Highly carbapenem-resistant Achromobacter xylosoxidans harboring blaNDM-1 in Myanmar","volume":"13","author":"Kirikae","year":"2025","journal-title":"Microbiol Spectr"},{"key":"key20260915130955_b34-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1128\/AAC.05640-11","article-title":"Genetic and biochemical characterization of a novel metallo-\u03b2-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya","volume":"56","author":"El Salabi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"621","key":"key20260915130955_b35-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00621","article-title":"Hospital acquired pneumonia due to Achromobacter Spp. in a geriatric ward in China: Clinical characteristic, genome variability, biofilm production, antibiotic resistance and integron in isolated strains","volume":"7","author":"Liu","year":"2016","journal-title":"Front Microbiol"},{"key":"key20260915130955_b36-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1128\/AAC.01463-07","article-title":"Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans","volume":"52","author":"Doi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key20260915130955_b37-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/trstmh\/trz109","article-title":"Achromobacter xylosoxidans in hospital environments: Still waters run deep!","volume":"114","author":"Marion-Sanchez","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key20260915130955_b38-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jcf.2022.11.001","article-title":"Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis","volume":"22","author":"Kerem","year":"2023","journal-title":"J Cyst Fibros"},{"key":"key20260915130955_b39-BR-25-4-02185","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.22207\/JPAM.17.4.11","article-title":"Antimicrobial susceptibility pattern and prevalence of the emerging nosocomial pathogen Achromobacter xylosoxidans in a North Indian tertiary care hospital","volume":"17","author":"Singh","year":"2023","journal-title":"J Pure Appl Microbiol"},{"key":"key20260915130955_b40-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1513\/AnnalsATS.201701-071OC","article-title":"Clinical outcomes associated with Achromobacter species infection in patients with cystic fibrosis","volume":"14","author":"Somayaji","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"key20260915130955_b41-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"00051","DOI":"10.1183\/23120541.00051-2019","article-title":"Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis","volume":"5","author":"Tetart","year":"2019","journal-title":"ERJ Open Res"},{"issue":"100202","key":"key20260915130955_b42-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2022.100202","article-title":"Case of recurrent Achromobacter xylosoxidans bacteraemia and PICC (peripherally-inserted central catheter) line infection in an immunocompromised patient","volume":"4","author":"Houlihan","year":"2022","journal-title":"Infect Prev Pract"},{"key":"key20260915130955_b43-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1128\/AEM.02293-13","article-title":"Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates","volume":"79","author":"Amoureux","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"key20260915130955_b44-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1086\/317461","article-title":"Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome","volume":"31","author":"Weitkamp","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"156","key":"key20260915130955_b45-BR-25-4-02185","article-title":"Bacteremia outbreak due to Achromobacter xylosoxidans in hospitalized COVID-19 patients","volume":"16","author":"Tsekoura","year":"2025","journal-title":"Microbiol Res"},{"issue":"1449","key":"key20260915130955_b46-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071449","article-title":"Achromobacter species: An emerging cause of community-onset bloodstream infections","volume":"10","author":"Isler","year":"2022","journal-title":"Microorganisms"},{"issue":"S851","key":"key20260915130955_b47-BR-25-4-02185","article-title":"Achromobacter xylosoxidans bacteremia in patients with cancer","volume":"2 (Suppl 1)","author":"S\u00e1nchez-Vargas","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key20260915130955_b48-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/0974-2727.163133","article-title":"Achromobacter xylosoxidans bloodstream infection in elderly patient with hepatocellular carcinoma: Case report and review of literature","volume":"7","author":"Raghuraman","year":"2015","journal-title":"J Lab Physicians"},{"key":"key20260915130955_b49-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.12998\/wjcc.v12.i20.4377","article-title":"Acute cholangitis with Achromobacter xylosoxidans bacteremia after endoscopic retrograde cholangiopan-creatography in hilar cholangiocarcinoma: A case report","volume":"12","author":"Jo","year":"2024","journal-title":"World J Clin Cases"},{"key":"key20260915130955_b50-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"CS63","DOI":"10.12659\/msm.881796","article-title":"A case of meningitis due to Achromobacter xylosoxidans denitrificans 60 years after a cranial trauma","volume":"17","author":"Manckoundia","year":"2011","journal-title":"Med Sci Monit"},{"key":"key20260915130955_b51-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.wneu.2020.05.283","article-title":"Polymicrobial intracerebral abscess growing mycobacterium avium complex and Achromobacter xylosoxidans: Case report and literature review","volume":"141","author":"Rotter","year":"2020","journal-title":"World Neurosurg"},{"key":"key20260915130955_b52-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/BF01713580","article-title":"Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter","volume":"23","author":"Ramos","year":"1995","journal-title":"Infection"},{"issue":"e01421","key":"key20260915130955_b53-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01421","article-title":"Mitral endocarditis caused by Achromobacter xylosoxidans in an older patient: Case report and literature review","volume":"27","author":"Kengni Tameze","year":"2022","journal-title":"IDCases"},{"issue":"e0072425","key":"key20260915130955_b54-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00724-25","article-title":"Clinical and microbiologic features of Achromobacter species: A 10-year, multicenter experience","volume":"63","author":"Bayless","year":"2025","journal-title":"J Clin Microbiol"},{"key":"key20260915130955_b55-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1155\/2011\/527412","article-title":"Achromobacter species endocarditis: A case report and literature review","volume":"22","author":"Derber","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"151664","key":"key20260915130955_b56-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2025.151664","article-title":"Biofilm-associated Achromobacter xylosoxidans prosthetic valve infective endocarditis","volume":"320","author":"Wackernagel","year":"2025","journal-title":"Int J Med Microbiol"},{"issue":"9454520","key":"key20260915130955_b57-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9454520","article-title":"Achromobacter xylosoxidans relapsing peritonitis and Streptococcus suis peritonitis in peritoneal dialysis patients: A report of two cases","volume":"2018","author":"Donderski","year":"2018","journal-title":"Case Rep Nephrol"},{"key":"key20260915130955_b58-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/00365540701558714","article-title":"Urinary tract infection due to Achromobacter xylosoxidans: Report of 9 cases","volume":"40","author":"Tena","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"key20260915130955_b59-BR-25-4-02185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgar.2024.10.223","article-title":"A rarely cause of urinary and bloodstream infections: Achromobacter Spp","volume":"39","author":"Dede","year":"2024","journal-title":"J Global Antimicrob Resist"},{"issue":"100234","key":"key20260915130955_b60-BR-25-4-02185","article-title":"Chronic otomastoiditis and otitis externa caused by Achromobacter xylosoxidans","volume":"17","author":"Curry","year":"2020","journal-title":"Otolaryngol Case Rep"},{"issue":"181","key":"key20260915130955_b61-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-12329-9","article-title":"Co-isolation of Achromobacter species and vibrio parahaemolyticus from a case of chronic suppurative otitis media in a sea swimmer: A case report","volume":"26","author":"Aboelsaad","year":"2025","journal-title":"BMC Infect Dis"},{"key":"key20260915130955_b62-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3855\/jidc.8747","article-title":"Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing","volume":"11","author":"Liu","year":"2017","journal-title":"J Infect Dev Ctries"},{"key":"key20260915130955_b63-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.atssr.2024.09.005","article-title":"Resected pulmonary Achromobacter xylosoxidans mimicking aspergillosis fungus ball","volume":"3","author":"Nakamura","year":"2024","journal-title":"Ann Thorac Surg Short Rep"},{"key":"key20260915130955_b64-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jgar.2024.01.023","article-title":"In vitro activity of cefiderocol against gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis","volume":"36","author":"Tunney","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"issue":"1352","key":"key20260915130955_b65-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101352","article-title":"In vitro activity of cefiderocol and comparators against carbapenem-resistant gram-negative pathogens from France and Belgium","volume":"11","author":"Oueslati","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"2473","key":"key20260915130955_b66-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122473","article-title":"In vitro activity of 22 antibiotics against Achromobacter isolates from people with cystic fibrosis. Are there new therapeutic options?","volume":"9","author":"Beauruelle","year":"2021","journal-title":"Microorganisms"},{"issue":"78","key":"key20260915130955_b67-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-024-00731-1","article-title":"Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus","volume":"23","author":"Jean-Pierre","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"874","key":"key20260915130955_b68-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13090874","article-title":"Cefiderocol for the treatment of infections by VIM-type-producing gram-negative bacteria","volume":"13","author":"Kirkegaard-Biosca","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"key20260915130955_b69-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40121-020-00385-4","article-title":"Salvage treatment with cefiderocol regimens in two intravascular foreign body infections by MDR gram-negative pathogens, involving non-removable devices","volume":"10","author":"Bodro","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"1686","key":"key20260915130955_b70-BR-25-4-02185","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121686","article-title":"Successful treatment of aortic endocarditis by Achromobacter xylosoxidans with cefiderocol combination therapy in a non-hodgkin lymphoma patient: Case report and literature review","volume":"11","author":"La Bella","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"key20260915130955_b71-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1093\/cid\/ciaa1847","article-title":"Cefiderocol for the treatment of adult and pediatric patients with cystic fibrosis and Achromobacter xylosoxidans infections","volume":"73","author":"Warner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key20260915130955_b72-BR-25-4-02185","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/ppul.24945","article-title":"Combining bacteriophages with cefiderocol and meropenem\/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient","volume":"55","author":"Gainey","year":"2020","journal-title":"Pediatr Pulmonol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:10:03Z","timestamp":1789467003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2026.2185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,10]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2026.2185","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}